Axogen (AXGN) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.69% |
| Dec 31, 2025 | 17.17% |
| Sep 30, 2025 | 29.23% |
| Jun 30, 2025 | -19.77% |
| Mar 31, 2025 | -30.98% |
| Dec 31, 2024 | -15.55% |
| Sep 30, 2024 | -49.34% |
| Jun 30, 2024 | -17.58% |
| Mar 31, 2024 | -19.32% |
| Dec 31, 2023 | -15.24% |
| Sep 30, 2023 | 15.51% |
| Jun 30, 2023 | 105.53% |
| Mar 31, 2023 | -9.43% |
| Dec 31, 2022 | -19.67% |
| Sep 30, 2022 | 66.10% |
| Jun 30, 2022 | 54.36% |
| Mar 31, 2022 | -108.61% |
| Dec 31, 2021 | -103.79% |
| Sep 30, 2021 | -99.17% |
| Jun 30, 2021 | -129.07% |
| Mar 31, 2021 | 30.48% |
| Dec 31, 2020 | -181.11% |
| Sep 30, 2020 | -141.22% |
| Jun 30, 2020 | 152.67% |
| Mar 31, 2020 | 195.42% |
| Dec 31, 2019 | 131.28% |
| Sep 30, 2019 | 72.86% |
| Jun 30, 2019 | 116.37% |
| Mar 31, 2019 | 109.25% |
| Dec 31, 2018 | 133.36% |
| Sep 30, 2018 | -404.28% |
| Jun 30, 2018 | -72.61% |
| Mar 31, 2018 | -54.22% |
| Dec 31, 2017 | -130.56% |
| Sep 30, 2017 | -47.82% |
| Jun 30, 2017 | -103.66% |
| Mar 31, 2017 | -21.04% |
| Dec 31, 2016 | -60.62% |
| Sep 30, 2016 | -15.21% |
| Jun 30, 2016 | -54.16% |
| Mar 31, 2016 | -93.55% |
| Dec 31, 2015 | -49.53% |
| Sep 30, 2015 | -39.90% |